These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9871622)

  • 1. Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing.
    Bailey S; Bolognese B; Buckle DR; Faller A; Jackson S; Louis-Flamberg P; McCord M; Mayer RJ; Marshall LA; Smith DG
    Bioorg Med Chem Lett; 1998 Jan; 8(1):23-8. PubMed ID: 9871622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of low affinity IgE receptor (CD23) processing.
    Bailey S; Bolognese B; Buckle DR; Faller A; Jackson S; Louis-Flamberg P; McCord M; Mayer RJ; Marshall LA; Smith DG
    Bioorg Med Chem Lett; 1998 Jan; 8(1):29-34. PubMed ID: 9871623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII).
    Christie G; Barton A; Bolognese B; Buckle DR; Cook RM; Hansbury MJ; Harper GP; Marshall LA; McCord ME; Moulder K; Murdock PR; Seal SM; Spackman VM; Weston BJ; Mayer RJ
    Eur J Immunol; 1997 Dec; 27(12):3228-35. PubMed ID: 9464810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.
    Bailey S; Bolognese B; Faller A; Louis-Flamberg P; MacPherson DT; Mayer RJ; Marshall LA; Milner PH; Mistry J; Smith DG; Ward JG
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3165-70. PubMed ID: 10560745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
    Steinman DH; Curtin ML; Garland RB; Davidsen SK; Heyman HR; Holms JH; Albert DH; Magoc TJ; Nagy IB; Marcotte PA; Li J; Morgan DW; Hutchins C; Summers JB
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2087-92. PubMed ID: 9873491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.
    Parvathy S; Oppong SY; Karran EH; Buckle DR; Turner AJ; Hooper NM
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):37-43. PubMed ID: 9355732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitors.
    Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
    Biochem Soc Trans; 1998 Aug; 26(3):S242. PubMed ID: 9765961
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.
    Pupovac A; Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2015 Jan; 93(1):77-85. PubMed ID: 25155463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.
    Mayer RJ; Flamberg PL; Katchur SR; Bolognese BJ; Smith DG; Marolewski AE; Marshall LA; Faller A
    Inflamm Res; 2002 Feb; 51(2):85-90. PubMed ID: 11926319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha.
    Parkin ET; Trew A; Christie G; Faller A; Mayer R; Turner AJ; Hooper NM
    Biochemistry; 2002 Apr; 41(15):4972-81. PubMed ID: 11939793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
    Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
    J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
    Codony-Servat J; Albanell J; Lopez-Talavera JC; Arribas J; Baselga J
    Cancer Res; 1999 Mar; 59(6):1196-201. PubMed ID: 10096547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease.
    Marolewski AE; Buckle DR; Christie G; Earnshaw DL; Flamberg PL; Marshall LA; Smith DG; Mayer RJ
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):573-9. PubMed ID: 9677315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase.
    Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
    Biochemistry; 1998 Feb; 37(6):1680-5. PubMed ID: 9484239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471.
    Wheeler DJ; Parveen S; Pollock K; Williams RJ
    Immunology; 1998 Sep; 95(1):105-10. PubMed ID: 9767464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs on the horizon: matrix metalloproteinase inhibitors.
    Rothenberg ML; Nelson AR; Hande KR
    Stem Cells; 1999; 17(4):237-40. PubMed ID: 10437989
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).
    Fray MJ; Dickinson RP
    Bioorg Med Chem Lett; 2001 Feb; 11(4):571-4. PubMed ID: 11229774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of proteolysis in Alzheimer's disease.
    Hooper NM; Trew AJ; Parkin ET; Turner AJ
    Adv Exp Med Biol; 2000; 477():379-90. PubMed ID: 10849764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
    Supuran CT; Briganti F; Mincione G; Scozzafava A
    J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.